Qube Research & Technologies (QRT)
LYRA

Qube Research & Technologies (QRT)’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,843
Closed -$70.6K – 3717
2024
Q4 		$70.6K Buy
+6,843
New +$75.3K ﹤0.01% 3048
2024
Q2 		– Sell
-2,638
Closed -$820K – 4363
2024
Q1 		$820K Buy
2,638
+1,529
+138% +$407K ﹤0.01% 2259
2023
Q4 		$291K Buy
1,109
+1,043
+1,580% +$189K ﹤0.01% 2600
2023
Q3 		$12.8K Buy
+66
New +$11.8K ﹤0.01% 3269

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LYRA Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2025, closing a stake of 6,843 shares — an estimated $70.6K sold.

Qube Research & Technologies (QRT) first reported a position in LYRA in Q3 2023 and held it in 4 quarters. The position peaked at $820K in Q1 2024. 57 funds tracked by Wall St. Rank hold LYRA as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining LYRA THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 6,843 LYRA THERAPEUTICS INC shares in Q1 2025, an estimated $70.6K.
  • Qube Research & Technologies (QRT) first reported a position in LYRA THERAPEUTICS INC in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s LYRA THERAPEUTICS INC position peaked at $820K in Q1 2024.
  • 57 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.